替雷利珠单抗联合化疗一线治疗晚期或转移性食管鳞状细胞癌的成本-效果分析
赵荧荧, 居文祥, 张小涵, 路萝兰, 沈爱宗
Cost-effectiveness analysis of tislelizumab combined with chemotherapy as first-line treatent for advanced or metastatic esophageal squamous cell carcinomas
ZHAO Yingying, JU Wenxiang, ZHANG Xiaohan, LU Luolan, SHEN Aizong
中国医院药学杂志
.
2025, (4): 418
-426
.
DOI: 10.13286/j.1001-5213.2025.04.08
